Microbial Epidemiology Patterns of Surgical Infection Pathogens

References

• Gold HS, Moellering RCJr. Antimicrobial drug resis-tance. N Engl J Med 1996; 335: 1445–53.
   PubMed Web of Science ®Google Scholar
• Ayliffe GM. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24, (Suppl): 74-9.
   Google Scholar
• Tenover FC. VRSA, VISA, and GISA: the dilemma behind the name game. Clin Microbiol News. 2000; 22: 49–53.
   Google Scholar
• Murray BE. Vancomycin-resistant enterococcal infec-tions. N Engl J Med 2000; 9: 710.
   Google Scholar
• Moellering RCJr. Introduction: Problems with antimi-crobial resitance in Gram-positive cocci. Clin Infect Dis 1998; 26: 1177–8.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Jones RA, et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. Int J Antimicrob Agents 2000; 13: 257–71.
   PubMed Web of Science ®Google Scholar
• Acar JF. Consequence of bacterial resistance to antibi-otics in medical practice. Clin Infect Dis 1997; 24 Suppl 1: S17–8.
   PubMed Web of Science ®Google Scholar
• Musher DM. Streptococcus pneumoniae. P.2128-2147. In: GL Mandell, JE Bennett, R Dolin (Hs), Principles and Practice of Infectious Diseases. Fifth Edition, 2000.
   Google Scholar
• Dowell SF, Kupronis BA, Zell ER, Stat M, Shay DK. Mortality from pneumonia in children in the United States, 1939 through 1996. N Engl J Med 2000; 342: 1399-407.
   Google Scholar
• Pallares R, Capdevila O, Grau I. Treatment options for resistant pneumococcal infections. Clin Microbiol Infect 1999; 5: 4S3-4S11.
   Google Scholar
• Tomasz A. The challenge of multiresistant Streptococcus pneumoniae: international initiatives in day-care centers and the use of molecular epidemiological tech-niques. Clin Microbiol Infect 1999; 5: 4S64-4S68.
   Google Scholar
• Goossens H, Sprenger MJW. Community acquired infections and bacterial resistance. BMJ 1998; 317: 54–57.
   Web of Science ®Google Scholar
• Felmingham D, Gruneberg RN and The Alexander Project Group. The Alexander Project 1996-1997: latest sus-ceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191–203.
   Google Scholar
• Marchese A, Ramirez M, Schito GC, Tomasz A. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolated in Italy during 1993-1996. J Clin Microbiol 1998; 36: 2944–2949.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Schmitz FJ, Jones ME, Acar J, Gupta R, Verhoef J, and the SENTRY Participants Group. Antimicrobial Resistance among community-acquired pneumo-nia isolates in Europe: First results from the SENTRY Antimi-crobial Surveillance Program 1997. Int J Infect Dis 1999; 3: 153–156.
   Google Scholar
• Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J, and the SENTRY Participants Group. Antimicrobial Susceptibility and frequency of occurence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998. Clin Infect Dis 2000; 30: 454–460.
   Google Scholar
• Marchese A, Schito GC. Osservatorio epidemiologico italiano per il monitoraggio delle resistenze agli antibiotici nei patogeni respirator' comunitari 1997-1999: significato per la pratica clinica. Giorn Ital Microbiol Med Odont Clin 2000; 4: 51–58.
   Google Scholar
• Novak R, Henriques B, Charpentier E, Normak S, Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999; 399: 590–593.
   PubMed Web of Science ®Google Scholar
• Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandell, Douglas and Bennett's Principles and practice of infectious diseases. Fourth edition, 1995: 1754–1776.
   Google Scholar
• Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1179–1181.
   PubMed Web of Science ®Google Scholar
• Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10 (4): 781–791.
   PubMed Web of Science ®Google Scholar
• Frank AL. Clonal features of community acquired methicillin resistant Staphylococcus aureus in children. Clin Infect Dis 2000; 30: 630–631.
   PubMed Web of Science ®Google Scholar
• Cookson BD. Methicillin-resistant Staphylococcus aureus in the community: new battlefronts or are battles lost? Infect Contr Hosp Epidem 2000; 21: 398-403.
   Google Scholar
• Archer GL. Staphylococcus epidermidis and other coagulase-negative staphylococci. In: Mandell, Douglas and Bennett's Principles and practice of infectious diseases. Fourth edition, 1995: 1777–1784.
   Google Scholar
• Schito GC, Debbia EA, Pesce A, and The Alexander Project Collaborative Group. Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). J Antimicrob Chemother 1996; 38, (Suppl. A): 97-106.
   Google Scholar
• May J, Shannon K, King A, French G. Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 189–197.
   PubMed Web of Science ®Google Scholar
• Rahman M. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections. J Antimicrob Chemother 1998; 41: 325–328.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguzi T, Tenover FC. Methicillin-resistant Staphylococcus aureus clini-cal strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135–136.
   PubMed Web of Science ®Google Scholar
• Centres for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to van-comycin-United States. Morbid Mortal Wkly Rep 1997; 46: 765–766.
   PubMedGoogle Scholar
• Ploy MC, Greland C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.
   PubMed Web of Science ®Google Scholar
• Siradzki K, Roberts RB, Harber SW, Tomasz A. The development of vancomycin resistance in a patient with methi-cillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340: 517–523.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Aritaka N, Hanki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–1673.
   PubMed Web of Science ®Google Scholar
• Ariza J, Pujol M, Cabo J, et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 1999; 353: 1587–1588.
   PubMed Web of Science ®Google Scholar
• Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC. Heterogenous vancomycin resistance in methicillin-resis-tant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol 2000; 32: 866–869.
   Google Scholar
• Fontana R, Ligozzi M, Mazzariol A, et al. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. Clin Infect Dis 1998; 27: (Suppl 1), S84–86.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use. J Antimicrob Chemother 2000; 46: 347–350.
   PubMed Web of Science ®Google Scholar